Skip to main content

Table 5 Association of sero-positivity to Chlamydia pneumoniae (CP), chlamydia heat shock protein (ch-hsp)60 with secondary fatal and non-fatal CVD events during follow up: Results of a multivariate analysis

From: Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study

   HR (95% CI)
   Crude Partially adjusted a Fully adjusted b
CP (IgA)     
  Negative 1ref 1ref 1ref
  Positive 1.60 (1.01–2.55) 1.60 (1.00–2.54) 1.46 (0.90–2.36)
CP (IgG)     
  Negative 1ref 1ref 1ref
  Positive 1.46 (0.92–2.33) 1.44 (0.91–2.30) 1.39 (0.87–2.23)
ch-hsp60     
  Negative 1ref 1ref 1ref
  Positive 1.12 (0.65–1.93) 1.09 (0.63–1.88) 1.01 (0.62–1.85)
  1. a = Adjusted for age and gender
  2. b = Adjusted for age, gender, HDL-cholesterol, smoking, alcohol consumption, school education, marital status, history of myocardial infarction, study centre
  3. (Test for interaction between diabetes and CP IgA (p = 0.60), CP IgG (p = 0.86) and ch-hsp60 (p = 0.46))